<p>This delivery order for fifty-nine dollars was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for 4562217848 PROHANCE 279.3 MG/ML VIAL 5ML, with a completion date of September 2023. The contract has a firm fixed price and will be performed by Amerisourcebergen Drug Corp in Conshohocken, Pennsylvania. No set-aside designation was used for this award in support of the Defense Logistics Agency's medical supply procurement programs.</p>
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $14,802.45, is for the supply of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract is a firm fixed price, delivery order type with a performance period ending on March 6, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This delivery order for $118 against an unidentified contract vehicle was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for the delivery of five vials of Prohance 279.3 mg/ml contrast agent. Place of performance will be the awardee's facility located in Conshohocken, Pennsylvania. No set-aside provisions were applied to this firm fixed price order, which is required to be completed by October 17, 2023. The Defense Logistics Agency manages the global supply chain for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $118.60 to Amerisourcebergen Drug Corporation for the supply of 20ml vials of MULTIHANCE 529 MG/ML contrast agent. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the product to its place of performance in Conshohocken, Pennsylvania within the period of performance between August 15-16, 2023. The Defense Logistics Agency routinely procures medical supplies and pharmaceuticals to support...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,624.38 to Amerisourcebergen Drug Corporation for the supply of 20 vials of MULTIHANCE 529 MG/ML contrast agent. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 26 to September 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested contrast media to...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,688 to Amerisourcebergen Drug Corporation for the supply of 20 milliliter vials of MultiHance 529 milligrams per milliliter contrast agent. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in September 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set...
The Defense Logistics Agency awarded a $118,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562174654 Multihance 529 MG/ML Vial 20ML. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by September 15, 2023 to support Department of Defense requirements. No major subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...
The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 20 vials of MultiHANCE 529 MG/ML contrast agent at a value of $5,631.23. Performance will take place in Conshohocken, Pennsylvania from June 30 through July 3, 2023. The firm-fixed-price order was awarded without any socioeconomic set-asides and will support the medical imaging needs of the Department of Defense through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,146.04 firm fixed-price contract is for the supply of Multihance, a contrast agent used in magnetic resonance imaging (MRI) procedures. The contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...